These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 13416708)

  • 1. The management of haemolytic disease in pregnancy.
    MEAGHER D
    J Ir Med Assoc; 1957 Apr; 40(238):124-5. PubMed ID: 13416708
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of Rh-haemolytic disease.
    Clarke CA
    Br Med J; 1968 Jan; 1(5583):57-8. PubMed ID: 5636752
    [No Abstract]   [Full Text] [Related]  

  • 3. The prevention of haemolytic disease of the newborn.
    Mellon DE
    Ir J Med Sci; 1967 Jun; 6(498):276-80. PubMed ID: 6069026
    [No Abstract]   [Full Text] [Related]  

  • 4. Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn.
    Daniels G; Finning K; Martin P; Soothill P
    Vox Sang; 2004 Nov; 87(4):225-32. PubMed ID: 15585017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of RhIG in the prevention of haemolytic disease of the newborn.
    Hirose TG; Mays DA
    J Obstet Gynaecol; 2007 Aug; 27(6):545-57. PubMed ID: 17896248
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of preimplantation genetic diagnosis in the management of severe rhesus alloimmunization: first unaffected pregnancy: case report.
    Seeho SK; Burton G; Leigh D; Marshall JT; Persson JW; Morris JM
    Hum Reprod; 2005 Mar; 20(3):697-701. PubMed ID: 15661826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fetal erythroblastosis & prophylactic Rh group examination in pregnant women; review & commentary on the new prophylactic Rh group study in connection with pregnancy tests].
    FREIESLEBEN E; FRIEDENREICH V
    Ugeskr Laeger; 1958 Mar; 120(13):405-11. PubMed ID: 13557081
    [No Abstract]   [Full Text] [Related]  

  • 8. Spontaneous exchange of blood between mother and fetus, preventing hemolytic disease in newborn.
    BERNER A
    J Int Coll Surg; 1958 Oct; 30(4):448-54. PubMed ID: 13588097
    [No Abstract]   [Full Text] [Related]  

  • 9. [Contribution of specific immunoglobulin anti-D to prophylaxis of haemolytic disease of the newborn].
    Bianu V; Zervos G; Kondi V; Balan S
    Rev Fr Gynecol Obstet; 1973 Oct; 68(10):569-71. PubMed ID: 17474215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
    Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C
    BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prophylactic measures in Rh incompatibility in pregnancy].
    TURCZYNSKI T
    Postepy Hig Med Dosw; 1958; 12(2):101-12. PubMed ID: 13601390
    [No Abstract]   [Full Text] [Related]  

  • 12. The occurrence of episodes of immunization in pregnancy associated with Rh haemolytic disease of the new-born.
    KELSALL GA; VOS GH; KIRK RL
    Med J Aust; 1959 Apr; 46(15):488-93. PubMed ID: 13656014
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
    Aylin T; Berkan G
    Indian Pediatr; 2005 Jan; 42(1):77-9. PubMed ID: 15695869
    [No Abstract]   [Full Text] [Related]  

  • 14. Fetal and neonatal cytopenias: what have we learned?
    Bussel JB
    Am J Perinatol; 2003 Nov; 20(8):425-31. PubMed ID: 14703590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Present-day management of the Rh-negative expectant mother and her erythroblastotic baby.
    WIENER AS
    Exp Med Surg; 1959; 17(1):15-30. PubMed ID: 13653065
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fetal erythroblastosis].
    BEAUDRY JL
    Lek Wojsk; 1960 Nov; 30():478-95. PubMed ID: 13688304
    [No Abstract]   [Full Text] [Related]  

  • 17. Prevention of repeat fetal loss in erythroblastosis.
    EVANS TN
    Obstet Gynecol; 1954 Jan; 3(1):80-6. PubMed ID: 13120055
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevention of fetal wastage due to erythroblastosis.
    MELNICK A
    J Am Osteopath Assoc; 1957 Apr; 56(8):486-7. PubMed ID: 13416024
    [No Abstract]   [Full Text] [Related]  

  • 19. [Contribution to the Rh problem with special consideration of the total understanding of fetal erythroblastosis].
    SCHEFFLER W
    Z Arztl Fortbild (Jena); 1957 Mar; 51(6):234-8. PubMed ID: 13443368
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immuno-hematological study of 130 married couples examined in the Centro Emodiagnostico of the Guardia Ostetrica Permanente of the city of Naples].
    SANTORO E; PAGNOTTA G; DE LUISE P
    Riv Emoter Immunoematol; 1960; 7():48-50. PubMed ID: 13746379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.